[1]
H. Aleksandrowicz, “HBV reactivation after immunosuppressive therapy and allogeneic HSCT – a silent threat in patients with chronic hepatitis B: a literature review”, J Educ Health Sport, vol. 88, p. 69714, Mar. 2026.